/Baxter%20International%20Inc_%20HQ-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Deerfield, Illinois-based Baxter International Inc. (BAX) functions as a healthcare company providing medical products and therapies. Valued at $16.2 billion by market cap, the company develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company's products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and research laboratories.
Shares of this global MedTech leader have underperformed the broader market over the past year. BAX has declined 18.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.9%. However, in 2025, BAX stock is up 8.5%, surpassing the SPX’s 1.9% rise on a YTD basis.